S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa

Atlas Arteria Stock Price, News & Analysis (OTCMKTS:MAQAF)

$3.60
0.00 (0.00%)
(As of 12/8/2023 ET)
Compare
Today's Range
$3.60
$3.60
50-Day Range
$3.27
$3.94
52-Week Range
$3.25
$5.01
Volume
N/A
Average Volume
2,177 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.31%
Price Target
N/A

MAQAF stock logo

About Atlas Arteria Stock (OTCMKTS:MAQAF)

Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in 22-kilometer toll road investors partnership II (TRIP II), the concessionaire for Dulles Greenway toll road located in Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.

MAQAF Stock Price History

MAQAF Stock News Headlines

Atlas Arteria (OTCMKTS:MAQAF) Trading Up 0.3%
Atlas Arteria Ltd MAQAF
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Atlas Arteria (MAQAF) Receives a Hold from RBC Capital
Bullish Atlas Arteria Insiders Loaded Up On AU$1.3m Of Stock
MAQAF - Atlas Arteria Limited
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
RBC Capital Sticks to Its Hold Rating for Atlas Arteria (MAQAF)
RBC Capital Sticks to Their Hold Rating for Atlas Arteria (MAQAF)
RBC Capital Reaffirms Their Buy Rating on Atlas Arteria (MAQAF)
Atlas Arteria Full Year 2022 Earnings: Misses Expectations
Atlas Arteria to bypass EastLink sale
ABN Amro Reaffirms Their Hold Rating on Atlas Arteria (MAQAF)
Positive Report for Atlas Arteria (MAQAF) from RBC Capital
See More Headlines
Receive MAQAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Infrastructure Operations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MAQAF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Graeme Francis Bevans (Age 65)
    MD, CEO & Executive Director
    Comp: $2.05M
  • Mr. David Collins
    Chief Financial Officer
  • Mr. Vincent Portal-Barrault
    Chief Operating Officer
  • Tess Palmer
    Director of Investor Relations
  • Mr. Clayton John McCormack B.Com.
    L.L.B., Company Secretary & General Counsel
  • Navleen Prasad
    Public Affairs Manager
  • Jim Dickson
    Corporate Development & Strategy Executive
  • Ms. Catherine Brain
    Group Executive of People & Culture
  • Mr. Paul Lynch B.Com.
    L.L.B., Joint Company Secretary
  • Mr. Ryan Reynolds C.F.A.
    Specialist of Forecasting and Analysis














MAQAF Stock Analysis - Frequently Asked Questions

Should I buy or sell Atlas Arteria stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Atlas Arteria in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MAQAF shares.
View MAQAF analyst ratings
or view top-rated stocks.

How have MAQAF shares performed in 2023?

Atlas Arteria's stock was trading at $4.24 at the beginning of 2023. Since then, MAQAF shares have decreased by 15.1% and is now trading at $3.60.
View the best growth stocks for 2023 here
.

Are investors shorting Atlas Arteria?

Atlas Arteria saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 2,043,400 shares, an increase of 26.8% from the October 15th total of 1,611,700 shares. Based on an average daily volume of 2,300 shares, the days-to-cover ratio is currently 888.4 days.
View Atlas Arteria's Short Interest
.

Is Atlas Arteria a good dividend stock?

Atlas Arteria (OTCMKTS:MAQAF) pays an annual dividend of $0.08 per share and currently has a dividend yield of 5.02%. MAQAF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.

How do I buy shares of Atlas Arteria?

Shares of MAQAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:MAQAF) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -